The stem cell-based therapy has emerged as a promising therapeutic strategy for treating
cardiovascular ischemic diseases (CVIDs), such as myocardial infarction (MI). However …

Therapeutic angiogenesis presents a potential approach for treating ischemic heart
diseases especially in patients who are not appropriate candidates for traditional …

Cardiovascular diseases (CVD) are a significant cause of human health harm. In the past,
stem cell therapy was reported to have functional defects, such as immune rejection …

For decades, mesenchymal stem (MSCs) cells have been used for cardiovascular diseases
as regenerative therapy. This review is an attempt to summarize the types of MSCs involved …

Abstract MicroRNAs (miRNAs), small non-coding RNAs, play a critical role in differentiation
and self-renewal of pluripotent stem cells, as well as in differentiation of cardiovascular …

Accumulating evidence has shown that endothelial progenitor cell-derived exosomes (EPC-
Exos) can ameliorate myocardial fibrosis. The purpose of the present study was to …

Mesenchymal stem cell (MSC) therapy is a promising approach against myocardial
infarction (MI). Studies have demonstrated that MSCs can communicate with other cells by …

Though experimental, stem cell transplantation has the potential to improve the condition of
the heart after myocardial infarction. It does so by reducing infarct size and inducing repair of …

Recent evidence indicates that exosomes derived from mesenchymal stem cells (MSCs)
confer protective effects against myocardial ischemia/reperfusion (I/R) injury. Exosomes are …

Exosomes are small vesicles (30–150 nm in diameter) enclosed by a lipid membrane
bilayer, secreted by most cells in the body. They carry various molecules, including proteins …